🚀 VC round data is live in beta, check it out!

BioHarvest Sciences Valuation Multiples

Discover revenue and EBITDA valuation multiples for BioHarvest Sciences and similar public comparables like Apetit, Zevia, Jamaica Broilers Group, Pieno zvaigzdes and more.

BioHarvest Sciences Overview

About BioHarvest Sciences

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.


Founded

2013

HQ

United States

Employees

87

Financials (LTM)

Revenue: $38M
EBITDA: ($4M)

EV

$86M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

BioHarvest Sciences Financials

BioHarvest Sciences reported last 12-month revenue of $38M and negative EBITDA of ($4M).

In the same LTM period, BioHarvest Sciences generated $23M in gross profit, ($4M) in EBITDA losses, and had net loss of ($10M).

Revenue (LTM)


BioHarvest Sciences P&L

In the most recent fiscal year, BioHarvest Sciences reported revenue of $35M and EBITDA of ($4M).

BioHarvest Sciences is unprofitable as of last fiscal year, with gross margin of 59%, EBITDA margin of (10%), and net margin of (32%).

See analyst estimates for BioHarvest Sciences
LTMLast FY202320242025202620272028
Revenue$38M$35M$13M$25M$35M
Gross Profit$23M$20M$6M$14M$20M
Gross Margin59%59%44%55%59%
EBITDA($4M)($4M)($10M)($7M)($7M)
EBITDA Margin(10%)(10%)(77%)(27%)(19%)
EBIT Margin(15%)(16%)(79%)(28%)(16%)
Net Profit($10M)($11M)($13M)($13M)($11M)
Net Margin(27%)(32%)(99%)(51%)(32%)

Financial data powered by Morningstar, Inc.

BioHarvest Sciences Stock Performance

BioHarvest Sciences has current market cap of $95M, and enterprise value of $86M.

Market Cap Evolution


BioHarvest Sciences' stock price is $4.18.

BioHarvest Sciences share price decreased by 0.7% in the last 30 days, and by 33.3% in the last year.

BioHarvest Sciences has an EPS (earnings per share) of $-0.49.

See more trading valuation data for BioHarvest Sciences
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$86M$95M0.0%-0.7%-11.3%-33.3%$-0.49

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

BioHarvest Sciences Valuation Multiples

BioHarvest Sciences trades at 2.3x EV/Revenue multiple, and (23.4x) EV/EBITDA.

See NTM and 2027E valuation multiples for BioHarvest Sciences

EV / Revenue (LTM)


BioHarvest Sciences Financial Valuation Multiples

As of May 3, 2026, BioHarvest Sciences has market cap of $95M and EV of $86M.

BioHarvest Sciences has a P/E ratio of (9.4x).

LTMLast FY202320242025202620272028
EV/Revenue2.3x2.5x6.8x3.4x2.5x
EV/EBITDA(23.4x)(23.8x)(8.8x)(12.4x)(12.8x)
EV/EBIT(15.6x)(15.4x)(8.6x)(12.3x)(15.4x)
EV/Gross Profit3.8x4.2x15.2x6.2x4.2x
P/E(9.4x)(8.5x)(7.5x)(7.3x)(8.5x)
EV/FCF(7.1x)(9.0x)(8.6x)(9.0x)(9.0x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified BioHarvest Sciences Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

BioHarvest Sciences Margins & Growth Rates

BioHarvest Sciences grew revenue by 29% and EBITDA by 5% in the last fiscal year.

In the most recent fiscal year, BioHarvest Sciences reported gross margin of 59%, EBITDA margin of (10%), and net margin of (32%).

See estimated margins and future growth rates for BioHarvest Sciences

BioHarvest Sciences Margins

Last FY202420252026202720282029
Gross Margin59%55%59%59%
EBITDA Margin(10%)(27%)(19%)(9%)
EBIT Margin(16%)(28%)(16%)(12%)
Net Margin(32%)(51%)(32%)(18%)
FCF Margin(28%)(38%)(28%)(39%)

BioHarvest Sciences Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth29%99%37%29%
Gross Profit Growth29%148%47%29%
EBITDA Growth5%(29%)(3%)(43%)
EBIT Growth(4%)(30%)(20%)(4%)
Net Profit Growth(28%)3%(14%)(28%)
FCF Growth79%(5%)1%79%

Data powered by FactSet, Inc. and Morningstar, Inc.

BioHarvest Sciences Operational KPIs

BioHarvest Sciences' revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.3M for the same period.

BioHarvest Sciences' Rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

BioHarvest Sciences' Rule of X is 64% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for BioHarvest Sciences
LTMLast FY202320242025202620272028
Rule of 4022%21%———
Bessemer Rule of X70%64%———
Revenue per Employee—$0.4M———
Opex per Employee—$0.3M———
S&M Expenses to Revenue45%46%50%37%38%
G&A Expenses to Revenue14%17%45%26%17%
R&D Expenses to Revenue16%15%27%19%15%
Opex to Revenue—75%123%83%75%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

BioHarvest Sciences Competitors

BioHarvest Sciences competitors include Apetit, Zevia, Jamaica Broilers Group, Pieno zvaigzdes, Enervit, Excelsior Alimentos, Miko, Omer-Decugis, HF Foods Group and FitLife Brands.

Most BioHarvest Sciences public comparables operate across Food & Beverages.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Apetit0.6x0.6x4.5x5.7x
Zevia0.4x0.4x(14.6x)(21.3x)
Jamaica Broilers Group0.6x—(58.7x)—
Pieno zvaigzdes0.4x—7.7x—
Enervit0.8x—8.2x—
Excelsior Alimentos1.5x—11.6x—
Miko0.5x0.5x4.0x3.9x
Omer-Decugis0.3x0.2x6.3x6.1x

This data is available for Pro users. Sign up to see all BioHarvest Sciences competitors and their valuation data.

Start Free Trial

BioHarvest Sciences Funding History

Before going public, BioHarvest Sciences raised $600K in total equity funding, across 1 round.


BioHarvest Sciences Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Mar-20Seed—$600K——

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About BioHarvest Sciences

When was BioHarvest Sciences founded?BioHarvest Sciences was founded in 2013.
Where is BioHarvest Sciences headquartered?BioHarvest Sciences is headquartered in United States.
How many employees does BioHarvest Sciences have?As of today, BioHarvest Sciences has over 87 employees.
Who is the CEO of BioHarvest Sciences?BioHarvest Sciences' CEO is Ilan Sobel.
Is BioHarvest Sciences publicly listed?Yes, BioHarvest Sciences is a public company listed on Nasdaq.
What is the stock symbol of BioHarvest Sciences?BioHarvest Sciences trades under BHST ticker.
When did BioHarvest Sciences go public?BioHarvest Sciences went public in 2019.
Who are competitors of BioHarvest Sciences?BioHarvest Sciences main competitors include Apetit, Zevia, Jamaica Broilers Group, Pieno zvaigzdes, Enervit, Excelsior Alimentos, Miko, Omer-Decugis, HF Foods Group, FitLife Brands.
What is the current market cap of BioHarvest Sciences?BioHarvest Sciences' current market cap is $95M.
What is the current revenue of BioHarvest Sciences?BioHarvest Sciences' last 12 months revenue is $38M.
What is the current revenue growth of BioHarvest Sciences?BioHarvest Sciences revenue growth (NTM/LTM) is 32%.
What is the current EV/Revenue multiple of BioHarvest Sciences?Current revenue multiple of BioHarvest Sciences is 2.3x.
Is BioHarvest Sciences profitable?No, BioHarvest Sciences is not profitable.
What is the current EBITDA of BioHarvest Sciences?BioHarvest Sciences has negative EBITDA and is not profitable.
What is BioHarvest Sciences' EBITDA margin?BioHarvest Sciences' last 12 months EBITDA margin is (10%).
What is the current EV/EBITDA multiple of BioHarvest Sciences?Current EBITDA multiple of BioHarvest Sciences is (23.4x).
What is the current FCF of BioHarvest Sciences?BioHarvest Sciences' last 12 months FCF is ($12M).
What is BioHarvest Sciences' FCF margin?BioHarvest Sciences' last 12 months FCF margin is (32%).
What is the current EV/FCF multiple of BioHarvest Sciences?Current FCF multiple of BioHarvest Sciences is (7.1x).
How many companies BioHarvest Sciences has acquired to date?BioHarvest Sciences hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies BioHarvest Sciences has invested to date?BioHarvest Sciences hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to BioHarvest Sciences

Lists including BioHarvest Sciences

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial